CIDRAP newsletters options
Four hard-hit countries—South Sudan, Angola, the DR Congo, and Sudan—account for about 90% of cases.
Two systematic reviews and meta-analyses found evidence that OMV-based meningococcal B vaccines offer moderate cross-protection.
About 6 in 10 presented accurate information on symptoms, preventive measures, and testing locations.
Overall, 57% of participants had evidence on PET/MRI of inflammation affecting the heart or lungs.
Reversing previous trends, trust in government vaccine information declined some in Democrats, but rose a bit among Republicans.
Long-COVID patients with dizziness on standing, mood changes, and musculoskeletal pain were the most likely to report unfavorable health.
In other US news, Los Angeles County has reported its fourth measles case of the year.
The agency says the move aims to ensure that foreign companies that produce food and essential medicines for US consumers receive the same level of oversight as domestic companies.
A study at a sexual health clinic finds that significant declines in chlamydia and syphilis were sustained nearly 2 years after doxy-PEP was introduced.
The WHO's advisory group will also weigh in on COVID vaccine composition this month.
The proportion of drug-resistant bacteria, and incidence rates of key multidrug-resistant pathogens, were up to three times higher in cancer outpatients than those without cancer.
Hospitalizations of infants for respiratory syncytial virus (RSV), human metapneumovirus, and adenovirus fell dramatically.
The suit from 19 states and the District of Columbia contends that major restructuring has cut life-saving programs and put extra burden on states to pay for health crises.
Also, health departments in Illinois, North Dakota, and Missouri reported more measles cases.
The freeze-dried formulation will be easier to store and transport than the liquid-frozen formulation that Bavarian Nordic has been supplying to the US government.
Protection, especially for men, was strongest 2 to 3 years following vaccination.
Resistance developed in 10% of those treated with baloxavir.
Of 4.4 million COVID-19 patients, 1.4% had new-onset diabetes, with 0.8% being type 2 and 0.02% type 1.
Background information on vaccine safety monitoring and standards for approving new vaccines can help Americans better follow the discussion and watch for key developments.
The two newer viruses scored slightly lower on some elements, but slightly higher on others, with a moderate overall risk similar to other H5N1 viruses.
